Article | 2019.08.06
The Institut Pasteur has a distinguished history of vaccine development as a means to improve global health. A stronghold of the Institut Pasteur in vaccines is the development of novel technologies for vaccine design and delivery with several candidates currently under clinical evaluation, either licensed to development and commercialization partners or under Institut Pasteur sponsorship.
Article | 2017.08.08
Make sure you bring along your health booklet (carnet de santé) or immunization record (carnet de vaccinations) if you have one.For children, no vaccinations can be administered without:the written permission of their parents or legal guardian;an identity document belonging to their parents or legal guardian.CHICKENPOX(NOT AVAILABLE) RecommendationsAdolescents aged between 12 and 18 who have...
Article | 2019.06.25
This thematic area gathers investigators with a common interest in translational research. It addresses the design, development and evaluation of candidate vaccines, therapeutics, diagnosis tools, and immunotherapies, for conversion of scientific breakthroughs into improved human health.
Article | 2024.03.12
VaccineDr. Sotiris MissailidisHead of Vaccine Innovation DevelopmentSotiris is managing the vaccine portfolio of the Institute Pasteur and leading the Innovation development of vaccine projects from basic research to clinical development, spin-off activities and industrial partnerships for vaccine-related projects. Sotiris joined the Institute Pasteur in 2024, having previously led for...
Article | 2020.10.14
Of all the vaccines developed at the Institut Pasteur for SARS-CoV-2 (the virus that causes COVID-19), the DNA vaccine undoubtedly involves the most novel approach, since no vaccine using this technology has yet been commercialized* (for humans).
Article | 2017.08.07
The medical and paramedical teams in the International Vaccination Center specialize in preventing diseases that affect travelers. They provide information and vaccinations for anyone planning to travel abroad.
News | 2024.05.29
Dedicated to the research of new immunotherapeutic vaccines in oncology and prophylactic vaccines, the aim of the joint Institut Pasteur - Oncovita laboratory is to design and develop vaccine candidates through to proof of concept in humans.
Article | 2018.01.30
A unique study on whooping cough (pertussis), in three regions of the world, estimates the duration of protection from the various vaccinations against pertussis.
Article | 2019.06.18
Vaccines have had a major positive impact on public health world-wide through disease prevention that can be measured in millions of lives saved. Despite the successes, we still face major challenges in vaccine and immunotherapy development for global, neglected, or newly emerging diseases and in our understanding of the determinants of vaccine protection. To address these issues, the Institut...
Article | 2024.04.30
Known for discovering a poliomyelitis vaccine, this researcher with a keen interest in the history of medicine also furthered use of the microscope and worked on health for Paris City Council.